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Role of Hypercholesterolemia and Inﬂammation in No/Slow Reﬂow During
Elective PCI in ACS patients
Chun Guang Qiu, Zayar Naing, Zhan Ying Han
First Afﬁliated Hospital of Zhengzhou University, Zhengzhou, China
Background: No/Slow Reﬂow is a nightmare in cath labs because of its serious
manifestations from severe chest pain to death. However, its exact etiopathogenesis is
still a mystery. We intend to ﬁnd its possible underlying mechanism(s).
Methods: Among the High Risk ACS patients for No/Slow Reﬂow (Hypertensive,
Diabetes, Chronic Total Occlusion, Stent Restenosis, SVG Stenosis, Arterectomy Done,
LeftMain andLADLesion,Multivessel andDiffuse Lesion)whohad undergoneElective
PCI fromOctober 2012 toOctober 2013, 23 patientswere found to haveNo/SlowReﬂow
and allocated as No/Slow Reﬂow Group and another 23 high risk patients were also
randomized and allocated as Control Group. Platelet and Plaque Factors, Inﬂammatory
Factors, Uric Acid, Cholesterol Factors, Symptom Onset to Balloon Interval (Days) and
Syntax Score for each patient were collected and compared between two groups.
Results: Uric Acid (p ¼ 0.031, r ¼ 0.318), Total Cholesterol (p ¼ 0.010, r ¼ 0.374)
and LDL (p ¼ 0.014, r ¼ 0.360) were the only correlation factors with No/Slow
Reﬂow group. However, Neutrophil to Lymphocyte Ratio (p¼0.017, CI¼2.135-
1969.758) and Total Cholesterol (p¼0.036, CI¼1.483-77581.262) were left as the
only independent factors of No/Slow Reﬂow after multivariable logistic regression.
After ROC curve analysis, Total Cholesterol got the highest Area Under Curve
(AUC¼0.703) with the best cut off point of 3.779 mmol/L (Sensitivity¼65%, Spe-
ciﬁcity¼65%) followed by Neutrophil to Lymphocyte Ratio.
Conclusion: Total Cholesterol and Neutrophil to Lymphocyte Ratio (New Inﬂam-
matory Marker) were signiﬁcantly increased in No/Slow Reﬂow Patients and the only
independent factors of No/Slow Reﬂow. Therefore, Hypercholesterolemia and
Inﬂammation may be possible mechanisms of No/Slow Reﬂow during Elective PCI.
TCTAP A-135
Coronary-pulmonary Artery Fistula Complicated with Coronary Artery
Aneurysm Treated with Transcatheter Coil Embolization
Takuo Kamibayashi
Fuchu Keijinkai Hospital, Fuchu-shi, Tokyo, Japan
Background: Recently, coronary-pulmonary artery ﬁstulas are frequent diseases
among congenital coronary deformity, and detected in 0.1 to 0.2% of patients who
underwent coronary angiography(CAG). However, it is rare to be complicated with a
coronary artery aneurysm in coronary-pulmonary artery ﬁstula. We report three cases
of coronary-pulmonary artery ﬁstula complicated with coronary artery aneurysm
treated with transcatheter coil embolization.
Methods: A representative case was 76-year-old woman who had been referred to our
center with chest pain on exertion since 5 years before. Electrocardiography showed
ST-T depression on inferior myocardium. CAG revealed 50% stenosis in mid right
coronary artery(RCA), and high-ﬂow coronary artery ﬁstula arising from the proximal
RCA to main pulmonary artery with coronary artery aneurysm.
Results: We successfully treated coronary-pulmonary artery ﬁstula and coronary ar-
tery aneurysm by transcatheter coil embolization. The patient has been free of
symptoms during 9 months follow up.
Conclusion: Surgical repair for coronary-pulmonary artery ﬁstula complicated with
coronary artery aneurysm was outstanding in japan, but it is suggested that trans-
catheter coil embolization is another option as effective and safe treatment.
TCTAP A-136
Primary Versus Tenecteplase-facilitated Percutaneous Coronary Intervention
with Routine Thrombus Aspiration and Closing Device in Patients with STEMI
Ji Young Park1, Jiyoung Park1, Sungkee Rye1, Seunghwan Kim1, Kyngtae Jung2,
Youjeong Choi2
1Eulji General Hospital, Seoul, Korea (Republic of), 2Eulji University Hospital,
Taejeon, Korea (Republic of)
Background: In current guidelines for patients with ST elevated Myocardial Infarction
(STEMI), primary percutaneous coronary intervention (PCI) suggests as the preferred
reperfusion strategy. In previous study, facilitated PCI had similar preprocedural TIMI
as compared with primary PCI group, but stent thrombosis increased in facilitated PCI
group due to prothrombotic condition after thrombolytic therapy, and intracranial
hemorrhage (ICH) increased in facilitated PCI group. However, performing dual anti-
platelet therapy, subcutaneous enoxaparin injection, routine thrombus aspiration, PCI
with newgeneration drug eluting stent (DES), and closing device in new era are expected
to change the results. The aim of this study is to compare the clinical outcomes between
primary PCI and tenecteplase- facilitated PCI in new era.
Methods: A total of 255 STEMI patients undergoing PCI were analyzed between
January 2006 and December 2012. The patients were divided into two groups such as
Primary PCI and Facilitated PCI. (Primary PCI group: n¼186, Facilitated PCI group:
n¼69). The patients had undergone PCI according to visiting time at emergency
room(ER): The patients who visited at ER from 6:00am to 0:00am had undergone
Primary PCI, and the patients who visited at ER from 0:00am to 6:00am had un-
dergone Tenecteplase-Facilitated PCI. Primary PCI had been performed within 90
minutes, and Tenecteplase-Facilited PCI had been performed within 6 hours. All
patients had received aspirin 300mg loading dose, clopidogrel 600mg loading dose,JACC Vol 63/12/Suppl S j April 22–25, 2014 j TCTAP Abstracts/POSTand exnoxaparin subcutaneous injection, and all patients had been treated with closing
device. Thrombus aspiration had been performed in patients who undergo post-
balloon dilatation and decrease post Thrombolysis In Myocardial Infarction (TIMI)
ﬂow to 0-2 ﬂow. We compared 12 months clinical outcomes including mortality,
reinfarction, target lesion revascularization (TLR), and major adverse cardiac event
(MACE) between two groups.
Results: Baseline clinical characteristics were similar between two groups. Angio-
graphic characteristics showed that Pre TIMI 0-2 ﬂow lesion (89% vs 68.4%,
p<0.001), Visible thrombus (77.7% vs 48.7%, p<0.001), and the use of GP IIb/IIIa
inhibitor (34.4% vs 15.4%, p¼0.022) were higher in Primary PCI group. Thrombus
aspiration was similar between two groups (37.1% vs 30.8%, p¼0.472). However,
after PCI, post TIMI 3 ﬂow was similar between two groups (85.6% vs. 91.2%,
p¼0.949), and there were no difference of 12 months clinical outcomes including
mortality (12.9% vs 7.7%, p¼0.432), TLR (7.0% VS 5.1%, P¼0.750), and MACE
(14.0% vs 17.9%, p¼0.618). Kaplan-Meyer curve showed that the cumulative inci-
dence of MACE was similar between two groups (Log rank¼0.521).
Conclusion: In the present study, Primary PCI group had more visible thrombus, and
frequently used GP IIb/IIIa inhibitor as compared with Tenecteplase-Facilited PCI.
However, after PCI, post TIMI 3 ﬂow and cumulative incidence of MACE up to 12
months were similar between two groups. Therefore, in new era, Tenecteplase-
Facilitated PCI can be considered as alternative to Primary PCI.
TCTAP A-137
Very Long-term Clinical Outcomes After Primary Stenting Using Sirolimus and
Paclitaxel-eluting Stents for Patients with STEMI
Tetsuya Ishikawa, Yosuke Nakano, Makoto Mutoh
Saitama Cardiovascular Respiratory Center, Kumagaya, Japan
Background: We sought to provide the retrospective comparison of very long-term
clinical outcomes after primary stenting using sirolimus (SES, Cypher Bx Velocity)
and paclitaxel (PES, TAXUS Express)-eluting stents for patients with STEMI.
Methods: The present study was a non-randomized, retrospective, and single center
study, recruiting 596 ﬁrst STEMI patients after successful either SES or PES place-
ment during from August 2004 to February 2007. Primary endpoint was the incidence
of severe cardiac events comprising of cardiac death, nonfatal recurrent MI, and
deﬁnite stent thrombosis.
Results: Except the clinical observation interval in the SES and PES groups (2173 786
vs. 1828  416 days, p < 0.001), baseline 25 variables were not signiﬁcantly different.
The incidence of severe cardiac events including 7 cases of very late deﬁnite stent
thrombosis (VLST) in the SES group (8.5%) was signiﬁcantly higher than that in the PES
groupwithoutVLST(3.1%,p<0.01).Cumulative primary endpoint-free ratio in theSES
group was not signiﬁcantly, but in trend, different from that in the PES group (p¼0.062).
Conclusion: Thus, the present study necessitated to evaluate the very long clinical
observation after DES placement for primary stenting for STEMI patients.
TCTAP A-138
Mode of Presentation of Patients with ST-segment Elevation Myocardial
Infarction in Singapore and Its Impact on Door-to-balloon Time and
Clinical Outcome
Kevin Kien Hung Quah, Than Htike Aung, David Foo, Paul Jau Lueng Ong,
Hee Hwa Ho
Tan Tock Seng Hospital, Novena, Singapore
Background: In the management of patients with ST-segment elevation myocardial
infarction (STEMI), the timeliness of reperfusion via primary percutaneous coronary
intervention (PPCI) is important in determining the morbidity and mortality. The
timeliness of PPCI is estimated by the door-to-balloon (D2B) time which has become
a key performance measure. Current guidelines recommend a D2B of < 90 minutes.
Given that most STEMIs occur out of hospital, the mode of presentation, whether by
emergency medical service (EMS) or by self-presentation (SP) is an important factor
inﬂuencing the timeliness of treatment and possibly clinical outcomes.
Methods: From January 2009 to December 2011, 957 patients ( 86 % male, mean age
of 58  12 years) presented to our hospital for STEMI and underwent PPCI. We
evaluated the relationship between the 2 different modes of presentation with median
door-to-balloon (D2B) time and in-hospital mortality. Data were collected retro-
spectively on baseline clinical characteristics, angiographic ﬁndings, therapeutic
modality and hospital course.
Results: The majority of STEMI patients (64%) utilized the EMS with the remaining
36% being SP. The percentage of patients achieving D2B < 90 minutes was 84%. The
medianD2B timewas signiﬁcantly shorter in patients presenting via EMS (57minutes vs
66minutes in the SP group, p< 0.0001). Despite shorter D2B time, the EMS group had a
signiﬁcantly higher in-hospital mortality rate than the SP group (6.4% vs 2.9%, p¼0.02).
Patients in the EMS group had a higher incidence of hypertension and hyperlip-
idemia and were signiﬁcantly older at presentation. They were more likely to have
triple vessel and obstructive left main disease on coronary angiography. The incidence
of cardiogenic shock was also signiﬁcantly higher in the EMS group.
Conclusion: Although the majority of patients utilised EMS and had a signiﬁcantly
shorter D2B time, they paradoxically had a higher rate of in-hospital mortality. Our
preliminary data suggested a possible threshold limit to D2B time in which further
reduction does not impact mortality in STEMI. Patients with sicker features were more
likely to use EMS in our study which was associated with increased mortality.ER/Acute Coronary Syndrome: STEMI, NSTE-ACS S39
